India’s Contract Research, Development, and Manufacturing Organization (CRDMO) sector is on a trajectory to achieve USD 22 billion to USD 25 billion by 2035, as outlined in a report by Boston Consulting Group (BCG) and Innovative Pharmaceutical Services Organization (IPSO). The sector is advancing at a 15 percent CAGR, surpassing global industry growth. This is largely driven by India’s cost advantage over Western competitors and its significantly faster project startup times.
About the Author
